Guggenheim reiterates Buy on EyePoint stock, cites trial progress Business May 7, 2026adminLeave a Comment on Guggenheim reiterates Buy on EyePoint stock, cites trial progress Advertisements Guggenheim reiterates Buy on EyePoint stock, cites trial progress Advertisements